Zydus Cadila gets USFDA nod to market generic cancer drug

The company has received final approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Gleevec tablets, Zydus Cadila said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2UY6O5b
via IFTTT